Large-Volume Injector Assembly for Aseptic Fluid Connection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing large volume injection devices face challenges in establishing a sterile or aseptic connection between the medicament container and the fluid flow path, complicating assembly and increasing costs.

Innovation Solution

A method involving a medicament delivery device with a moveable medicament container sled, needle insertion mechanism, and drive mechanism, allowing for aseptic connection by securing the medicament container in the sled and activating the drive mechanism to apply pressure to the plunger, thereby establishing a fluid connection with the fluid path.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional large volume injection devices are assembled in a clean room environment to ensure sterility, then the sterility of the device is improved, but the manufacturing complexity and cost increase

Engineering Contradiction:
ImprovesterilityVSAvoidassembly complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The device is divided into sterile components (medicament container, fluid path) and non-sterile components (external housing, drive mechanism). The sterile components are pre-assembled and sealed in a sterile barrier, allowing final assembly to occur outside the clean room while maintaining sterility through the barrier until the moment of use.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The sterile components are prepared and sealed in advance within a sterile barrier package. This preliminary sterile assembly eliminates the need for clean room conditions during final device assembly, as the sterile integrity is already established before the device leaves the manufacturing environment.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If traditional large volume injection devices use complex sterilization and connection mechanisms, then the sterility is improved, but the manufacturing cost increases

Engineering Contradiction:
ImprovesterilityVSAvoidmanufacturing cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The device employs a disposable sterile barrier package that is discarded after single use. This eliminates the need for expensive, complex sterilization mechanisms and allows standard manufacturing processes to be used, significantly reducing manufacturing costs while maintaining sterility through the barrier until use.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Reliability

If the medicament container is securely connected to the fluid path, then the sterility is improved, but the device complexity increases

Engineering Contradiction:
ImprovesterilityVSAvoidconnection mechanism complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The connection between the medicament container and fluid path is pre-established within the sterile barrier during manufacturing. This preliminary connection eliminates the need for complex connection mechanisms during patient use, as the sterile integrity and fluid connection are already established before the device leaves the manufacturing environment.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables aseptic connection of the medicament container with the fluid path without requiring a clean room environment for all assembly steps, reducing complexity and cost while maintaining sterility.

Implementation Method 1

activating the drive mechanism to cause the drive mechanism to apply pressure to the plunger of the medicament container

Methodology Applied
Scientific EffectPressure: Pressure Increase

Data Source

PatentUS20260069764A1Method of operating a large-volume delivery device
Publication Date: 2026.03.12 SANOFI AVENTIS DEUT GMBH
  • US20260069764A1 patent drawing
  • US20260069764A1 patent drawing
  • US20260069764A1 patent drawing

AI summary

A method of operating a medicament delivery device is provided. The method can include selecting a medicament delivery device, comprising: an external housing including a substantially rigid body; a moveable medicament container sled; a needle insertion mechanism; a fluid path operable to connect a needle of the needle insertion mechanism with a medicament container; a medicament container including a container body and plunger, wherein the medicament container is secured in a portion of the moveable medicament container sled; and a drive mechanism. The method can include applying the medicament delivery device to a skin surface of a patient; and activating the medicament delivery device to cause the drive mechanism to apply pressure to the plunger of the medicament container, wherein activating the medicament delivery device comprises releasing a latch mechanism of the drive mechanism.